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A2U α2u-globulin
AP Alkaline phosphatase
APC antigen-presenting cell
Asn Asparagine
AU Arbitrary units
BCA Bicinchoninic acid
BCIP 5-bromo-4-chloro-3-indolyl phosphate
BCR B-cell receptor
BLAST Basic local alignment search tool
CD Cluster of differentiation or cluster designation
CDP Disodium 2-chloro-5-(4-methoxyspiro(1,2-dioxetane-3,2-
(5-chloro)-tricyclo(3.3.1.1)decan)-4-yl)phenyl phosphate
C-terminal/us Carboxy-terminal end of a polypeptide chain
CTL Cytotoxic T lymphocyte
D Aspartic acid
Da Dalton
DTH Delayed type hypersensitivity
ELISA Enzyme-linked immunosorbent assay
e-RABP Epididymal retinoic acid binding protein
Fc Fragment crystallizable or fragment complement binding
FPLC Fast protein liquid chromatography
G Glycine
Gly Glycine
HPHT High performance hydroxyapatite
IEF Isoelectric focusing
IFN-γ Interferon gamma
Ig Immunoglobulin
IL Interleukin
IU International Units
IUIS International Union of Immunological Societies
kDa kilo Dalton
LAA Laboratory animal allergy
LAK cell Lymphokine activated killer cell
M
r
Molecular weight
MAb Monoclonal antibody
Met Methionine
MHC Major histocompatibility complex
MUP Mouse urinary protein, if not otherwise stated
MW Molecular weight
N-terminal/us Amino-terminal end of a polypeptide chain
NBT Nitro blue tetrazolium chloride
NK cell Natural killer cell
OD Optical density
2PAS Periodic acid-Schiff
PBS Phosphate buffered saline
Phe Phenylalanine
pI isoelectric point
p-NPP p-Nitrophenyl phosphate
PVDF Polyvinylidene difluoride
RAST Radioallergosorbent test
RLU Relative light units
SDS-PAG/E Sodium dodecyl sulfate polyacrylamide gel / electrophoresis
Ser Serine
SPT Skin prick test
3-D Three dimensional
TBS Tris buffered saline
TCR T-cell receptor
Thr Threonine
TNFβ Tumour necrosis factor beta
Tris Tris(hydroxymethyl)aminomethane
W Tryptophan
w/v weight/volume
WHO World Health Organization
ZIA Zone immunoelectrophoresis assay
3Contents
1. Introduction 1
The immune system 1
Activation of T cells 1
T-helper cells 2
Cytokines 3
B cells and Ig class switching 4
IgE and IgE receptors 4
Allergy 5
Hypersensitivity ractions 6
Exposure to laboratory animals 7
Rat allergens 7
Properties of a2u-globulin and pre-albumin 8
Allergens from various laboratory animals 9
Aims of the present study 10
2. Methodology 11
Urine collection 11
Separation and purification 11
The Centriprep procedure 11
Precipitation of α2u-globulin 11
SDS-PAGE and IEF as analytical tools for monitoring the purification procedure 12
Total protein determination 12
Affinity chromatography 12
Zone immunoelectrophoresis assay 12
Detection of glycoproteins in gels after SDS-PAGE 13
Detection of glycoproteins on Western Blotting membranes 13
Patients and controls 13
Skin prick testing 13
Specific IgE 14
Total IgE 14
Agarose gel electrophoresis 14
SDS-PAGE prior to immunoblotting 14
Immunoblotting 14
Colloidal gold staining 14
Dot blotting 14
Chemiluminescence procedures 15
Peptide synthesis 16
ELISA screening 16
Allergen-specific IgE analysis 16
4Enzymatic cleavage 16
Molecular mass determination of the peptides 16
Computer analysis of the amino acid sequence of α2u-globulin for prediction
of epitopes, homology and peptide mass 17
3. Results 18
Urine sampling and precipitation of α2u-globulin (I) 18
Protein concentration procedures (I, II) 18
Isolation and purification studies (II) 21
Identification and characterization of certain proteins (II, V) 21
Quantification by chemiluminescence (III) 22
IgE-binding to rat urine extract (IV) 23
Epitope mapping (V) 24
Homology (V) 25
4. Discussion 26
Urine sampling 26
Concentration of proteins 27
Purification 27
Electrophoretic studies 28
Identification and molecular characterization 29
Glycosylation 29
Quantification of proteins by chemiluminescence 30
Allergenicity studies of rat urinary proteins 31
IgE binding proteins in rat saliva 33
Stability of allergenic proteins 33
Epitope mapping 34
Homology studies 35
Future aspects and significance of the studies in relation to diagnosis
of allergy and immunotherapy 36
Concluding remarks 39
Summary 40
Sammanfattning 42
Acknowledgements 44
References 46
11. Introduction
The immune system
For protection against invading pathogenic microorganisms, vertebrates have
developed complex biological defense mechanisms collectively called the
immune system. The primary function of the immune system is to remove
infectious agents, thereby minimizing the damage they could cause. When an
immune response is generated a variety of cells and tissues are involved in
recognizing, attacking and eliminating foreign substances in the body.
 The immune system can be divided into two compartments which interplay
with each other. The first is the non-specific, innate, or natural immune response
and the second the antigen-specific, acquired or adaptive. Natural immunity is
comprised of physical obstacles, e.g. the skin and the mucous membranes, as well
as physiological barriers which include increased body temperature, the acid pH
of the stomach and secretory components such as lysozymes in tears, bactericidal
fatty acids, and interferons and the complement system. A variety of chemical
mediators such as histamine as well as hydrolytic enzymes also contribute to
innate immunity. Cells involved in the innate immune response include
granulocytes, macrophages, mast cells and natural killer (NK) cells. Phagocytosis
is another important natural defense mechanism.
Acquired immunity is characterized by specificity, diversity, memory, and
self/nonself recognition. Lymphocytes have a central role in all adaptive immune
responses. There are two categories of lymphocytes, the antibody-producing B
lymphocytes (B cells) and the T lymphocytes (T cells). Lymphocytes specifically
recognize and eliminate foreign substances called antigens both inside host cells
and outside, in the blood or tissue fluids. B- and T-cells combat their target
antigens by humoral and/or cellular mechanisms. Both types of lymphocytes have
antigen-specific surface receptors. B cells interact with intact antigen via their
antigen-specific B-cell receptor (BCR), a complex of membrane-bound
immunoglobulin and a disulfide-linked heterodimer. T cells express T-cell
receptors (TCR) which in association with a cell membrane complex of
polypeptides known as CD3 form a TCR-CD3 membrane complex. T-cell
receptors recognize processed antigen associated with molecules encoded by
major histocompatibility complex (MHC) and which are present on the surface of
antigen-presenting cells (APC). Both B- and T-cell receptors exist in diverse
forms which are generated by random rearrangements of multiple gene segments
during the maturation of B- and T-cells. The communication between the cells in
the immune system is regulated by cytokines, a group of low molecular weight
proteins secreted by leukocytes.
Activation of T cells
The recognition of antigen by certain T lymphocytes is fundamental for the
generation and regulation of an effective immune response. T lymphocytes arise
from the hematopoietic stem cells in the bone marrow and subsequently they
2migrate to the thymus to mature. In the lymph nodes the T cells proliferate and
differentiate into memory T cells and various effector T cells such as T helper-
(Th) and cytotoxic (Tc) cells. These subsets are distinguished by their expression
of specific surface proteins. The Th cells express the CD4 marker and Tc cells the
CD8 marker. These markers strengthen the relatively weak interaction between
TCR and the peptide-major histocompatibility complex (MHC). T cells are only
able to recognize processed antigen which has been degraded into peptide
fragments. The processed antigen in association with highly polymorphic MHC
on the surface of antigen-presenting cells such as macrophages, B lymphocytes or
dendritic cells is recognized by the T cell receptor on mature T cells. CD4+  T
cells recognize their specific antigenic peptides in association with MHC class II,
whereas CD8+ T cells bind antigenic peptides in association with MHC class I. To
fully activate Th cells a co-stimulatory signal is needed which is provided by the
antigen presenting cell. One such ligand-receptor system consists of CD28
expressed by CD4+ cells and its ligands B7-1 (CD80) and B7-2 (CD86) expressed
on the antigen-presenting cells (24, 83). After activation the CD4+ cells express
CTLA-4 (CD152) which also binds to the B7-1/B7-2 ligands but with a much
higher affinity. The delivery of co-stimulatory signals prevents anergy. Interaction
between the TCR-CD3 complex and the peptide-MHC molecule leads to the
production of IL-2. Autocrine stimulation of IL-2 promotes the proliferation of Th
cells. These cells secrete various cytokines which are crucial for the activation of
macrophages, B- and Tc-cells. Cytotoxic-T lymphocytes, activated by the
cytokine IL-2, mediate membrane damage to altered self-cells, leading to cell
lysis.
T-helper cells
Mosmann originally described two types of CD4+ T-helper cells in the murine
system (123), denoted Th1- and Th2-cells and which differ in their biological
functions based on the different cytokine profiles they secrete. T cells that do not
display restricted Th1- or Th2-like cytokine profiles, but rather intermediate ones,
are known as Th0 cells (58, 173). In humans the segregation between cells that
produce Th1 and Th2 cytokines is not as clear as in mouse (149). Th1 cells are
involved in the cell-mediated immune response. Typical human Th1 cytokines
include IFN- g , TNF b , and IL-2 which mainly mediate delayed-hypersensitivity
reactions and activate macrophages. Cytokines produced by Th2 cells are IL-4,
IL-5, IL-6, IL-10, and IL-13 (13, 124) with principal effects on B cell growth and
differentiation.
Certain Th1 derived cytokines downregulate Th2 cells and vice versa (161).
IFN-g  and IL-4 are such cytokines with reciprocal effects. The Th1 cytokine IFN- g
inhibits the IgE synthesis (139) while the Th2 cytokine IL-4 induces the IgE
production and simultaneously inhibits the production of TNF- a  and IL-1 (63).
Differentiation of CD4+ cells into either Th1- or Th2-cells determines the
outcome of an immune response. Factors suggested to be of importance for this
regulation are: cytokine environment, antigen dose and route of administration,
type of antigen-presenting cells and their secretion of cytokines as well as the
3activity of co-stimulatory molecules (1, 133, 161). The immune response is also
highly influenced by the genetic constitution of the individual.
On the basis of the cytokine profiles there is evidence for the existence of
functionally distinct subsets also among the CD8+ Tc cells (155, 160).
Cytokines
Cytokines, the regulators of the immune system, are important for the allergic
reactions. The intensity and duration of the immune response are regulated by
cytokines. They stimulate or inhibit the activation, proliferation and
differentiation of various cells and regulate their secretion of antibodies and
cytokines. In this thesis mainly cytokines involved in type I hypersensitivity
reactions will be discussed, i.e. the Th2 subset of cytokines. Elevated
concentrations of Th2 cytokines are generally seen in allergic diseases and in
helminthic infections. The Th1 and Th2 subsets of cytokines have cross-
regulating functions. The Th1 cytokine IFN- g  inhibits the proliferation of the Th2
subset, while the Th2 cytokine IL-10 decreases the secretion of IFN- g  by
downregulating the MHC class II expression on monocytes and macrophages. IL-
12 secreted by macrophages induces proliferation of Th1- and NK cells and
thereby an increased IFN- g  production. Thus, IL-12 promotes Th1-type of
response while the Th2 cytokines IL-4 and IL-10 promote a Th2-type of response
by inhibiting the IL-12 production. The cytokine environment present at the time
when Th cells differentiate influences the type of subset developed. In vitro
activation of Th cells by an antigen together with IL-4 results in a Th2 subset
whereas activation by the same antigen but in the presence of IFN- g  gives rise to a
Th1 subset.
Here follows an overview of principal features of certain cytokines.
IL-4, secreted by Th2 cells is involved in immunoglobulin class switching from
IgM/IgG to IgE as well as enhancing proliferation and differentiation of activated
B cells. In resting B cells and macrophages the expression of class II MHC is up-
regulated by IL-4 (135). The macrophages’ phagocytic activity is also increased
by the pleiotropic IL-4. It stimulates growth of mast cells and co-stimulates
activation of antigen-primed B cells. Further, the cytokine induces proliferation of
thymocytes and T cells. Overproduction of IL-4 is seen in allergic individuals,
possibly due to polymorphism within the promotor of the IL-4 gene (165).
IL-5, secreted by Th2 cells (177) stimulates proliferation and differentiation of
activated B cells, induces Ig class switch to IgA and promotes growth and
differentiation of eosinophils.
IL-10, secreted by Th1-, Th2- and activated B cells and macrophages,
suppresses IFN- g  production in macrophages and thus indirectly reduces cytokine
production by Th1 cells (122). In antigen-presenting cells the expression of MHC
class II molecules is down-regulated by IL-10.
IL-12, secreted by macrophages, B cells (182) and dendritic cells, stimulates
proliferation in NK cells and lymphokine activated killer (LAK) cells as well as
activated Th1 cells (112, 159). In activated Tc cells IL-12 acts synergistically with
IL-2 to induce differentiation of cytotoxic T lymphocytes (CTL).
4IL-13, secreted by Th cells, is an important regulator of inflammatory response
as it inhibits activation and release of inflammatory cytokines in macrophages
(42). Ig class switching to IgG4 or IgE in B cells is regulated by IL-13 (100, 144).
IFN- g , secreted by Th1-, Tc- and NK cells, enhances the activity of
macrophages (25). IFN- g  increases the expression of MHC class I and II
molecules in many cell types. The cytokine inhibits the proliferation of Th2 cells
and blocks the IL-4-induced class switch to IgE.
B cells and Ig class switching
The B lymphocytes arise from hematopoietic stem cells in the bone marrow.
Naive B lymphocytes leave the bone marrow with unique antigen-binding
receptors on their membrane, i.e. antibody molecules often of both IgM and IgD
isotypes but with the same unique antigen specificity. This specificity is
determined prior to contact with the antigen by random rearrangements of gene
segments encoding the variable regions of the antibody molecule. Upon activation
B cells will differentiate into antibody forming cells. During the primary immune
response IgM molecules of rather low affinity are secreted and the IgD expression
is downregulated. The B cells will then migrate from the primary follicles in the
spleen or lymph nodes into the germinal centers where the secondary immune
response takes place. In the germinal center B cells will undergo somatic mutation
i.e. small changes like deletions or additions of nucleotides in the
immunoglobulin gene sequence. To complete the maturation of affinity B cells
will be selected by their ability to bind antigen. In the germinal center B cells with
high-affinity receptors will interact with antigen on follicular dendritic cells and
as a result the bcl-2 gene is expressed. The bcl-2 protein prevents B cells from
undergoing apoptosis. Antigenic stimulation of the B cell results in Ig class
switching i.e. changed biological function of the antibody. However, the antibody
specificity is maintained after class switching. The isotype switching from
IgM/IgG to IgE is dependent on signals from CD4+ Th cells, the CD40 ligand
(82), and the cytokines IL-4 or IL-13 (193), secreted by antigen-activated Th2
cells. Likewise IL-10 promotes IgG1 and IgG3 switching (122). After the switch
the B cells will leave the germinal center to become memory- or plasma cells. The
signalling through the CD40 marker is crucial for the differentiation of B cells
into memory cells. In the absence of this signal, B cells undergo terminal
differentiation into plasma cells (14).
IgE and IgE receptors
When allergens - that is, antigens that elicit allergic reactions - enter the body a
local reaction occurs and IgE-secreting plasma cells will move to the site.
Allergens trapped in the lymph nodes may give rise to large quantities of locally
produced IgE molecules, secreted by medullary plasma cells, which will leave the
lymph nodes through the efferent lymphatic vessel. The antibodies enter the
circulation and are thus distributed throughout the body. Free serum IgE has a
half-life of a few days but remains for many months when bound to the high
affinity binding IgE receptor Fc e RI which is present on mast cells or basophils
(121). In normal individuals the serum level of total IgE is within the
5concentration range 0.1-0.4 m g/ml compared to 10 mg/ml for IgG. In type I
hypersensitive individuals the total concentration of IgE is often increased but
seldom higher than 1 m g/ml.
The IgE heavy chain contains, besides one variable domain, four constant
domains, one more than IgG, and no hinge region. Secreted IgE antibodies bind
with high affinity to IgE specific receptors on mast cells and basophils. The IgE
receptor interacts with the Fc region of the e  heavy chain, i.e. the Ce 2 and/or C e 3
domains. After sensitization and upon repeated exposures to the allergen, the
membrane bound IgE molecules become cross-linked. This cross-linkage of the
Fce RI receptor-bound IgE triggers the degranulation of the mast cell. The
degranulation causes the release of various pharmacologically active mediators
which in turn mediate type I allergies, such as asthma, hay fever, and eczema. In
addition to the high affinity receptor there are two forms of the low affinity
receptor: Fc e RIIa and Fc e RIIb. These two forms of the low affinity receptor are
also known as CD23. Fc e RIIa is expressed on B cells before they differentiate
into plasma cells. Fc e RIIb is expressed on B cells, T cells, monocytes, and
eosinophils but only after induction by the cytokine IL-4 (43). The Fc e RII
receptor has a regulatory role for the intensity of the IgE response. Atopic
individuals have higher levels of Fc e RII on their lymphocytes and macrophages
than nonatopics. Crosslinking of Fce RII with allergens or IgE-immune complexes
leads to the release of leukotrienes, TNF and IL-1 (47). Fc e RII also plays a role in
IgE-mediated reactions by enhancing antigen presentation to T cells (188).
Allergy
The word allergy originates from the Greek language and means ”other action” or
”changed reactivity” and was originally coined by von Pirquet in 1906 (22, 145).
By definition, an allergy or hypersensitivity reaction is an exaggerated physical
response to certain antigens, typically common environmental substances that
normally produce little or no response in the general population. In sensitive
individuals, however, antigens elicit reactions that may cause tissue damage and
lead to various symptoms in the airways, gut, and skin. The most common allergic
diseases are rhinitis, asthma, atopic dermatitis, urticaria, and food allergies.
IgE antibodies are thought primarily to have evolved to play a role in the
defense against parasitic worm infestations. In the absence of Th1 inducing
infections the Th1/Th2 balance could be disturbed and when that occurs Th2
mechanisms could be triggered and promote allergic disorders. Consequently, in
industrialized countries where parasitic worms are rare, the synthesis of IgE
antibodies is regarded as an unwanted immune response. Hence, allergy is often
said to be an unfortunate side effect. It is suggested that the decline of the
frequency of viral and bacterial infections, due to improved living standards and
immunization programs, could cause an increase in the incidence of allergy (39,
162). Environmental factors may also play important roles in the development of
allergic diseases. Thus, pollutants in the air may increase mucosal permeability
and thereby enhance allergen entry (178). The level of allergen exposure, the
nutrition status of the individual, intestinal flora, stress, and passive smoking are
other factors claimed to contribute to the allergic disorder (8, 23, 80).
6Consequently, allergy affects the quality of life for many persons. Reduced
ventilation and changed dietary habits are also suggested to be adjuvants
enhancing IgE synthesis (178, 203). Thus the ”Western lifestyle” can be an
important risk factor for the development of allergic diseases.
There is a genetic predisposition for atopy and the development of specific IgE
antibodies against common environmental antigens. Parental history of allergy is
thus a risk factor for atopy. When both parents have an atopic disease there is a
50% risk that the children will develop allergy and with one allergic parent there
is a 30% risk. The atopy concept has recently been discussed since there is still
some controversy about the precise clinical definition (102).
 Hypersensitivity reactions
According to Coombs and Gell there are four types of hypersensitivity reactions
(65). This thesis deals exclusively with type I hypersensitivity reactions.
The type I hypersensitivity reaction is IgE-mediated and induced by specific
antigens referred to as allergens. The allergens activate Th2 cells which will start
to secrete IL-4. This will induce Ig class switching in B cells followed by
production of IgE molecules, which will bind to specific IgE-Fc receptors on mast
cells and basophils. Later, when exposed to the same allergen, the cell-bound IgE
antibodies will become crosslinked, resulting in degranulation of mast cells and
the release of pharmacologically very potent mediators such as histamine,
serotonin, heparin and various enzymes. Also other mediators appear
simultaneously, for instance the platelet-activating factor, chemotactic factors,
and inflammatory mediators such as prostaglandins and leukotrienes. The effects
caused by the mediators are inflammation, vasodilation, smooth muscle spasm
and chemotaxis. In some individuals the immediate phase of IgE-dependent
hypersensitivity reactions or the first stage of inflammation is followed by a late
reaction or the second stage of inflammation. This is due to invasion of
inflammatory cells associated with the mucosal edema and secretion of
inflammatory activators.
The type II reaction develops when IgG binds to either self- or foreign antigen
on cells, leading to phagocytosis, complement-mediated lysis or antibody-
dependent cell-mediated cytotoxicity.
Type III reactions occur when large quantities of immune complexes are
formed and not cleared away thoroughly. This type III hypersensitivity reaction is
often observed when large amounts of antigen enter the bloodstream and when the
level of circulating antibodies specific for that particular antigen is high.
Types I-III are immediate reactions, appearing within a few minutes up to
several hours after exposure to an antigen.
Type IV is a delayed hypersensitivity reaction (DTH) where symptoms occur
within a few days and is mainly mediated by T-cells or macrophages. Many
contact-dermatitis reactions are of type IV or TDTH -mediated.
7Exposure to laboratory animals
Handling of laboratory animals involves increased risk of developing allergy (11,
33, 69). This is a world-wide occupational problem. Mice and rats are the most
frequently used laboratory animals. In Sweden 131 496 mice and 118 404 rats
were used during 1996 in research laboratories, pharmaceutical companies and
industries, and at universities and hospitals (54). Thus, employees at such
workplaces, students, veterinarians and breeders are exposed to laboratory
animals. In addition, mice and rats are becoming more and more popular as pets,
which may contribute to development of allergy.
Within the first three years of exposure to laboratory animals allergic symptoms
like rhinitis, conjunctivitis, asthma or urticaria occur in sensitized individuals with
a prevalence of 20-30% (11, 76, 164).
Another factor, besides exposure and work task, that may affect the allergy
response is physical work load, because the inhaled air volume increases the more
strenuous the work. The inhaled volume may be more than three times higher than
at rest. It should also be mentioned that the fume cupboards used in many
workplaces are often designed to protect the experiment rather than the person
doing the experiment, i.e. the air blows straight into the face of the personnel,
carrying allergens with it.
Many epidemiological and prospective studies of exposure and risk factors for
developing allergy to laboratory animals have been carried out (76, 147, 164).
This contributes to the understanding of the problem and our ability to counteract
laboratory animal allergy.
Rat allergens
Allergens involved in rat hypersensitivity reactions have been found in fur, saliva,
urine, feces, skin, and serum of rats (130, 198, 199). However, the major source is
considered to be the urine since stronger skin test reactions in rat sensitive patients
are obtained with urine extract compared to preparations from other rat materials
(198). Protein excretion into the urine due to spontaneous nephropathy is
increased with the age of the rats (27, 202). When the urine dries, the allergens
may become airborne as small particles (49, 50, 131). Thus, individuals are
exposed to the allergens either via direct skin contact or when they inhale airborne
particles. The allergens in the fur and the skin are most probably contaminations
transferred from urine or saliva. One of the most well studied and most dominant
protein in fertile male rat urine is a 2u-globulin (67, 105, 108, 130). The name a 2u-
globulin originates from the observation that the protein’s electrophoretic mobility
is similar to that of serum a 2-globulin (93, 152), and u stands for urine. In
accordance, another protein in rat urine has been called pre-albumin, since this
protein migrated similarly to serum prealbumin in horizontal starch-gel
electrophoresis (152). Longbottom and co-workers introduced another term for
a 2u-globulin, namely a 2-euglobulin, which originates from its tendency to
precipitate when dialyzed for 4-5 days against deionized water (105). The names
have been used in parallel. However, this has later been found confusing and
misleading. To make matters worse, the rat urinary a 2u-globulin is registered as
alpha-2u-globulin or major urinary protein (MUP) in the SWISS-PROT protein
8sequence database with the accession number P02761. This may cause even more
confusion since the mouse major urinary protein is also abbreviated MUP. These
two MUPs are not the same protein even though they share high sequence
homology (34). Pre-albumin was not renamed.
Both pre-albumin and a 2u-globulin were shown to be potent allergens (105,
130) and in addition isoforms (21). It was recently proposed that these two rat
isoallergens should be called Rat n 1.01 and Rat n 1.02, respectively (171).
According to the WHO/IUIS Allergen Nomenclature Subcommittee (86) the first
three letters in the nomenclature name correspond to the first letters of the genus
name. The fourth is the first letter of the species name. The Arabic numerals
represent the order in which the allergens have been identified and described. In
recent years it has often been found that a certain allergenic protein can occur in
molecular forms that differ only slightly, e.g. by a few residues in the amino acid
sequence. Allergens with very similar physical, chemical and immunochemical
structures but slightly different isoelectric points, and sharing at least 67% of the
amino acid sequence identity are termed isoallergens (98). Isoallergens are
indicated by an additional two numerals. Thus, Rat n 1.01 stands for Rat (Rattus),
n (norvegicus) and 1 (the first allergen identified). The figures 01 indicate that this
is the first isoallergen identified in Rattus norvegicus.
Despite the dominance of Rat n 1.01 and Rat n 1.02, also other proteins present in
rat urine may be allergenic (67, 77, 78).
Properties of a 2u-globulin and pre-albumin
Important characteristics for description of proteins are isoelectric point (pI) and
molecular weight (Mr), which is unitless, or molecular mass given in units of
Dalton. The latter two terms are used interchangeably to indicate the size of
proteins. The pI is determined by the composition of the protein i.e. the relative
proportions of different amino acids, their charged groups and some other
molecular moieties that may occur, e.g. bound carbohydrates. A variety of mainly
chromatographic procedures have been used to purify rat urinary proteins,
particularly, a 2u-globulin (51, 89, 94, 95, 105, 152, 192).
a 2u-Globulin is synthesized in the liver, secreted into the blood and excreted in
the urine (153, 154). It represents 30% of the total urinary protein (89) and is
produced in adult male rats under androgen control. However, a very similar
protein in urine from female rats has been reported to occur but at a much lower
concentration; approximately 120 times less (192). Further, this protein is also
present in other secretory tissues like the submaxillary, lachrymal and mammary
glands as well as in the anterior pituitary both in female and male rats, although it
is not as abundant as in male rat urine (10, 27, 70, 110, 205). Mature a 2u-globulin
has a molecular weight of 18 700 Da and contains 162 amino acids (183). Earlier
published pI values are 5.1, 5.3 and 5.5 (105). The pI values for pre-albumin were
reported to be 4.2 and 4.3 (105) and its molecular weight 21 000 Da as determined
by SDS-PAGE (67, 107).
Diet has been found to influence the excretion of a 2u-globulin. In rats, a protein-
free diet i.e. 0% casein, was shown to reduce significantly the concentration of
a 2u-globulin in urine (129). Excretion of the protein is age-dependent in rats (67,
9128). After the age of 160 days the albumin becomes the major component of
male rat urine. The excretion of albumin accelerates with age due to spontaneous
development of renal lesions and nephropathy. Protein droplet nephropathy and
renal tumors also occur in the male rats and are caused by several chemical
compounds, for instance d-limonene and dichlorobenzene which are present in
unleaded gasoline. This results in an accumulation of a 2u-globulin in the proximal
tubular cells (27).
a 2u-Globulin is a transport protein for hydrophobic molecules and it belongs to
the lipocalin family. The lipocalin name refers to the capability of binding
lipophilic molecules as well as the binding mode in which the ligand is enclosed
by the protein (140). a 2u-Globulin in rat urine and the closely related major urinary
protein (MUP) in mouse urine, serve as carriers for odorants, which could act as
sexual attractants or for territorial marking (18, 59). The proteins may also bind
degraded sex hormones i.e. pheromones. Pheromones are messenger substances
used for communication between members of the same species. These
pheromones are volatile components of low molecular mass which are easily
released from drying urine. The three-dimensional structure of a 2u-globulin has
been determined and to some extent also its ligand binding properties (34, 81, 97).
The lipocalins are a rapidly growing protein family which includes the previously
named a 2u-globulin superfamily (31, 140). Proteins in a superfamily have similar
folding patterns and a sequence identity < 50%. For lipocalins the sequence
homology is about 20% (60). Typical members of the a 2u superfamily are low
molecular weight transport proteins with a similar three-dimensional structure
where the polypeptide chain forms a b -barrel (27). Included in this superfamily
are human, rat and mouse urinary proteins, b -lactoglobulins, and serum retinol-
binding proteins (31). Most of the lipocalins are found in vertebrates but some
have been identified in arthropods and even in bacteria (59) and the database
PROSITE, release 15. Because of the continual expansion of this family, the
lipocalins are no longer primarily classified as transport proteins. Currently known
family members possess a variety of different functions as for example in
enzymatic synthesis, cell regulation and pheromone signalling (59).
Allergens from various laboratory animals
Not only people who handle rats and mice but also those who handle other
animals are at risk for development of allergy. Thus, saliva, fur, and dander from
rabbits and guinea pigs are other sources of allergens (105, 109, 142, 143, 200).
These allergens are also proteins, mainly in the molecular mass range 10-40 kDa
(101). Yet other species used as laboratory animals which could cause allergy are
cats and dogs. The major cat allergen, Fel d 1, with a molecular weight of 35 kDa,
has been detected both in saliva and in skin epithelium (7, 20, 32, 40). Can f 1, the
major dog allergen, has been characterized as well (61, 68, 158, 169).
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Aims of the present study
Although our knowledge about allergenic proteins has increased during recent
years, still further biochemical and immunological studies are needed at the
molecular level to better understand laboratory animal allergies.
The aim of this thesis was to improve the knowledge about allergens present in rat
urine with special emphasis on:
1) isolation, identification and characterization of the major urinary proteins;
2) studying the allergenicity of rat urinary proteins using improved methods;
3) examination of, in some detail, the IgE binding regions of the major allergens.
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2. Methodology
The methods used in papers I-V are described briefly below. For itemized
explanations see the Materials and Methods sections in the respective papers.
Methods not mentioned in papers I-V are described in greater detail in this
section.
Urine collection
Urine was collected in separate portions, day time from 8 a.m. to 4 p.m. and
during nights from 4 p.m. to 8 a.m., from fertile male 14 - 15 week old Sprague-
Dawley rats housed individually in metabolic cages. These cages are constructed
to separate urine and faeces in special containers. The cages are also specially
designed for collection of food- and drinking-water waste to avoid contamination
of urine and faeces samples. Bladder urine samples were obtained by bladder
puncture as described in paper I.
Separation and purification
The collected urine samples were processed as described in paper II followed by
concentration by ultrafiltration centrifugation (paper I) or a chromatographic
method utilizing hydroxyapatite (78), (paper II). Subsequently, rat urinary
proteins were separated and purified by liquid chromatography using the
Pharmacia FPLC system which involved molecular size separation by gel
filtration on a Hiload Superdex column followed by charge separation on an ion
exchange column, Mono Q (II). The two purified dominating proteins were
identified as different forms of the same parent protein, a 2u-globulin, by using
amino-acid compositional analysis and sequence analysis as well as mass
spectrometry.
Rat albumin (Nordic Immunological Laboratories, Tilburg, The Netherlands)
was purified further by gel filtration as described in paper IV, (21).
The Centriprep procedure
CentriprepTM concentrators (Amicon, W. R. Grace & Co., Danvers, MA, USA) are
disposable ultrafiltration devices for use in centrifuges. They are suitable for
concentrating and desalting biological samples in the 5-15 ml volume range.
Concentration and desalting to a certain extent occur simultaneously. Dialyzed rat
urine was spun in a CentriprepTM C30 unit with a nominal membrane cutoff
corresponding to 30 000 MW. The C30-filtrate was re-spun in a CentriprepTM C10
unit with a nominal membrane cutoff of 10 000 MW (I).
Precipitation of a 2u-globulin
The day-time and night-time urine samples were centrifuged at 3000g for 20 min.
Aliquots of the resulting supernatant were then thoroughly dialyzed against
deionized water (105) or against 50 mM ammonium hydrogen carbonate (107) or
against 4 mM sodium phosphate buffer pH 6.8 (78). The dialyzed urines were
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centrifuged (3000g, 20 min), the supernatants decanted and the precipitates
resuspended in 50 mM ammonium hydrogen carbonate.
SDS-PAGE and IEF as analytical tools for monitoring the purification procedure
Protein extracts and liquid chromatography fractions were separated under
reducing conditions by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) (78) using gel slabs (10-20% linear gradient). Ready-made Phast
SDS-PAG gradient gels (10-15%) and the Phast System â  (Pharmacia Biotech)
were also used. Proteins in the gels were stained with Coomassie Brilliant Blue
R250 (2, 78) or by silver as described earlier (2) and the Phast System â  manual,
respectively. Horizontal SDS electrophoresis with ExelGelTM SDS, gradient 8-18%
(Pharmacia) were run as well. Silver staining was done according to the
manufacturer’s instructions.
Urinary proteins concentrated by CentriprepTM i.e. ultrafiltration centrifugation,
were analyzed under slightly different conditions (I) namely by placing samples in
precasted 1% (w/v) agarose wells on linear 4-25% (w/v) polyacrylamide gradient
gels (75 x 75 x 3 mm) (116, 117). The gels were silver stained (115).
Native rat urinary proteins (untreated sample) were analyzed by isoelectric
focusing in the Phast System â  using ready-made gels with the pH ranges 3-9 and
4 - 6.5. The Phast gels were silver stained in accordance with the Phast System â
manual.
Total protein determination
For quantification of total protein concentrations to ensure adequate sample
loading in electrophoresis and liquid chromatography both the BCA
(Bicinchoninic acid) protein assay (Pierce, Rockford, IL, USA) and the
Coomassie â  Protein Assay (Pierce), a variant of the Bradford method, were used
according to the manufacturer’s recommendations.
Affinity chromatography
For the affinity purification of hydroxyapatite concentrated rat urinary proteins
(HPHT-extract) the monoclonal antibody, mAb(6) specific against rat urinary
allergen, Rat n 1 i.e. both isoallergens, (148) was used. The monoclonal antibody
was immobilized to an AminoLink column (Pierce). The AminoLink column was
processed according to the manual of ImmunoPure â  Antigen/Antibody
Immobilization Kit 1 (Pierce).
Zone immunoelectrophoresis assay
For determination of specific proteins, zone immunoelectrophoresis assay, ZIA,
was used in principle as previously described (194). Briefly, a 1.3% (w/v) solution
of agarose in 0.04 M Tris-Tricine buffer pH 8.6 was mixed with antibodies at
55° C. Antibodies specific to rat albumin (Nordic) or transferrin (Organon
Teknika-Cappel, Turnhout, Belgium) were used. The twenty glass tubes in the
zone immunoelectrophoresis apparatus were filled up to a few centimeters from
their tops with the antibody-containing agarose solution. Dilutions of standards
and rat urinary protein samples were applied on the upper gel surface in each tube
and the electrode vessels were subsequently filled with buffer. Electrophoresis
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was performed overnight. The antibodies formed complexes with the antigens
giving immobile antigen-antibody precipitation zones in the gel rods. The rods
were then pushed out of the glass tubes and placed on a piece of GelBond foil
(FMC, Glostrup, Denmark). Immunoprecipitates could be seen directly in oblique
light or visualized with Coomassie blue (79) or silver staining (196). The amount
of protein in a sample was linearly related to the distance from the upper gel
surface to the front of the immunoprecipitation zone. Samples were analyzed in
duplicate. Standard curves were obtained with different concentrations of rat
serum (DAKO, Glostrup, Denmark) when analyzing transferrin and different
standard concentrations of rat albumin (Nordic) for albumin determination.
Detection of glycoproteins in gels after SDS-PAGE
Sodium dodecyl sulfate-polyacrylamide gels were stained for glycoproteins
according to Dubray et al. (46) using periodic acid-Schiff reagent (PAS) (Sigma,
St. Louis, MO, USA) omitting the enhancing step i.e. the simplified silver
staining, due to non-specific staining of the rat urinary proteins with this enhanced
detection method. Ribonuclease B (Sigma) was used as a positive control and b -
lactoglobulin (Sigma) as a negative control.
Detection of glycoproteins on Western Blotting membranes
Detection of carbohydrate moieties in glycoproteins immobilized to a membrane
was executed according to the principle of the GlycoTrackTM kit (Oxford
GlycoSystems Ltd, Abingdon, U. K.). Briefly, the sample immobilized to a PVDF
membrane after Western blotting is oxidized with periodate. Biotinylation using
biotin-hydrazides followed by probing with a streptavidin-alkaline phosphatase
conjugate was used for detection. Subsequently, visualization was performed with
the substrate NBT/BCIP (Bio-Rad, Hercules, CA, USA) giving a colored
precipitate.
Patients and controls
Serum samples used were from patients with a clinical history and clear
symptoms of allergy to rat, verified by skin prick test (SPT) with the rat extract
Soluprick â  from (ALK, Hørsholm, Denmark) and also confirmed by specific
serum IgE determination using RAST as described (4). The patients had been
working as laboratory technicians or as animal keepers. Sera from persons without
any allergic symptoms were used as controls. The samples were taken with
informed consent and the studies were approved by the Ethics Committee of Lund
Hospital, University of Lund, Sweden.
Skin prick testing
Skin prick tests with gel filtration fractions corresponding to Rat n 1.01 (pre-
albumin) or Rat n 1.02 ( a 2u-globulin) (170) as well as the HPHT-extract were
performed on the volar aspect of the forearm as described (4, 78). The tests were
carried out in collaboration with the Department of Occupational Dermatology,
University Hospital, Lund.
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Specific IgE
Radio allergosorbent test (RAST) was used to quantify serum IgE antibodies
specific to rat urinary proteins. The test was performed at the Department of
Clinical Immunology, Karolinska Hospital, Stockholm.
Total IgE
The total concentration of serum IgE was determined by paper radioimmuno-
sorbent test (PRIST â ) (Pharmacia) and the results were expressed in kU/l. These
analyses were performed at the Department of Occupational Dermatology,
University Hospital, Lund.
Agarose gel electrophoresis
Electrophoresis was run vertically in 1.5% w/v agarose gels in a Miniprotean II
apparatus (Bio-Rad) (2). The upper buffer contained 0.1% w/v SDS, 100 mM
glycine and 25 mM Tris. The lower buffer contained 100 mM sodium acetate.
From each SDS-treated sample (non-reduced) 10 m l was applied (III).
SDS-PAGE prior to immunoblotting
Rat urinary proteins were separated by SDS-PAGE under non-reducing conditions
in a Mighty SmallTM apparatus (Hoefer, San Francisco, CA, USA) using gel slabs
(10 - 20% linear gradient) (IV). Samples were mixed with an equal volume of a
cocktail of 2% w/v SDS, 0.1% w/v bromophenol blue, 20% w/v sucrose and then
heated at 100° C for 5 min. Electrophoresis was performed vertically with cooling
at 15° C in principle as described (90).
Immunoblotting
After electrophoresis the proteins were transferred to a PVDF membrane (0.2 m m)
(BioRad) by electroblotting in a Mighty Small Transfer Unit (Hoefer) (IV).
Briefly, a sandwich was built up with foam sponges, blotting paper, membrane
and gel and placed in a cassette. The cassette was inserted into a vertical slot in
the buffer chamber, and the Western blotting procedure started. If more than one
serum was studied at the same time the membrane was after completion of the
transfer cut into strips. The strips could then be analyzed individually.
Subseqently the membrane was blocked and thereafter incubated, in diluted
patient sera, at 37° C for at least 3 1/2 h, but often overnight for practical reasons.
After washings the strips were further incubated for at least 1 1/2 h at 37 ° C with a
1:2000 dilution of alkaline phosphatase conjugated goat-anti-human IgE (Tago,
Biosource, Camarillo, CA, USA).
Colloidal gold staining
AuroDyeTM forte (Amersham, Little Chalfont, UK) ready-to-use solution was used
for total protein staining of rat urinary proteins transferred to PVDF membranes
(IV).
Dot blotting
On a moist PVDF membrane (0.2 m m) protein samples were applied as dots. The
sample volume was between 10 m l and 200 m l. Volumes over 40 m l required
sequential application. Blocking, antibody incubation and washing procedures
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Peptide synthesis
Octapeptides, overlapping four amino acids, corresponding to the a 2u-globulin
sequence were synthesized on derivatised polyethylene rods arranged in a
microtiter plate format using the MultipinTM Peptide Synthesis Kit (Chiron
Technologies, Clayton, Australia) (V). Briefly, Fmoc-amino acid active esters
were coupled to the pins by repetitive cycles; one amino acid per cycle from the
C-terminus to the N-terminus of the peptide chain.
ELISA screening
The set of synthesized peptides was scanned for sequential epitopes in an ELISA
system as follows (V). The pins with the peptides were blocked in a pre-coating
buffer and thereafter incubated overnight at 4 ° C in a 50-fold dilution of patient
sera. After washing, the pins were incubated at room temperature in a dilution
1:500 of alkaline phosphatase conjugated antibody, goat anti-human IgE-AP
(Biosource). Subsequently the pins were washed and immersed in freshly
prepared substrate solution of p-Nitrophenyl Phosphate, pNPP, (Sigma). The
optical density was read at 405 nm in a Vmax ELISA plate reader (Molecular
Devices, Sunnyvale, CA, USA). The peptides, covalently linked to the pins, could
be repeatedly tested by careful removal of bound antibodies after each assay.
To confirm the specificity of the binding, inhibition studies with serum samples
preincubatedwith a HPHT-extract, i.e. concentrated rat urinary proteins, were
performed. Briefly, the blocked pins were incubated overnight with preincubated
serum followed by washing and incubation with the secondary antibody as
described above.
Allergen-specific IgE analysis
Purified proteins corresponding to the allergens Rat n 1.02 ( a 2u-globulin) or Rat n
1.01 (pre-albumin) (21) were tested in ELISA (V). Microtiter plates were coated
with the respective proteins and then separately incubated with different dilutions
of individual patient sera. Alkaline phosphatase conjugated goat anti-human IgE
(Tago), diluted 1:500, was added. The substrate pNPP (Sigma) was used and the
optical density was read at 405 nm in a plate reader (SPECTRAmaxTM 250,
Molecular Devices).
Enzymatic cleavage
The purified proteins corresponding to the allergens Rat n 1.01 or Rat n 1.02 were
after separation by SDS-PAGE digested using the enzyme endoproteinase Lys-C
(74, 75). Resulting peptides were separated by reversed-phase liquid
chromatography on a Smart System (Pharmacia Biotech) and then sequence
analysed with a 494A PE-Applied Biosystem instrument (Applied Biosystems,
Foster City, CA, USA) (V).
Molecular mass determination of the peptides
Molecular masses of isolated peptides were determined by mass spectrometry on a
BIFLEX MALDI-TOF (Bruker Franzen Analytik GmbH, Bremen, Germany)
according to the manufacturer’s recommendation (V).
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Computer analysis of the amino acid sequence of a 2u-globulin for prediction of
epitopes, homology and peptide mass
For B-cell epitope prediction the model developed by Chou and Fasman (37) was
utilized (V).
The BLAST program (Basic Local Alignment Search Tool) (6) was used to
search comprehensive protein sequence databases for other proteins having amino
acid sequence homology to a 2u-globulin (V).
Theoretical enzymatic cleavage of a 2u-globulin with Lys-C was performed with
the program PeptideMass (12), (V).
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3. Results
Urine sampling and precipitation of a 2u-globulin (I)
The influence of the collection method and the type of urine sampled in the
starting material was investigated. Rat urine samples were collected partly in
metabolic cages (day-time and night-time) and partly by bladder puncture.
Electrophoretic analysis under reducing conditions showed that rat urine
contained a complex mixture of proteins as revealed by silver staining. Both the
collection method and the time of sampling influenced the pattern and the protein
contents in the bands. For instance, proteins with a molecular weight of 14 400 or
less were missing in the day-time cage urine. The bladder urine contained the
highest protein concentration and the day-time cage urine the lowest.
The effect of different storage conditions of the urinary samples was also
examined. Hence, protein modification due to prolonged incubation time at room
temperature was studied. It was found that incubation times as long as 72 h had
little effect on the urine proteins in bladder and day-time samples. Night-time urine
was more affected by this procedure, however, and displayed reduced amounts
particularly of low molecular weight proteins and above all the proteins with Mr
10 000, 16 000, and 32 000 which were abundant in bladder urine. In addition, long
time storage in the freezer at -70 ° C resulted in a change of the distribution pattern
towards lower molecular weight components, especially proteins below Mr 32 800
(unpublished results). This change was seen both with night- and day-time urine.
Bladder urine, however, was not investigated with regard to this aspect.
Three different buffers were tested to evaluate the effectiveness of precipitating
a 2u-globulin by dialysis. 50 mM ammonium hydrogen carbonate buffer,  4 mM
phosphate buffer pH 6.8 and deionized water were used. Precipitation of a 2u-
globulin occurred only after dialysis against deionized water. The precipitate was
removed by centrifugation and the supernatant was analyzed for the presence of
a 2u-globulin. a 2u-Globulin was not totally precipitated, since the electrophoretic
analysis of the supernatant showed presence of this protein. Nor did the
precipitate contain solely a 2u-globulin as indicated by electrophoresis following
ultrafiltration concentration of the resuspended precipitate. Thus several low
molecular weight polypeptides co-precipitated with the a 2u-globulin protein.
Protein concentration procedures (I, II)
One centrifugation method utilizing ultrafiltration and one chromatographic
method were tested for the concentration of urinary proteins. Two molecular
weight cut-off sizes were used in the Centriprep ultrafiltration concentration
method (I), 10 000 and 30 000, respectively. The fraction retained after Centriprep
10 000 contained preferably proteins of molecular weights < 30 000. The
Centriprep method was quick but gave incomplete recovery of low molecular
weight proteins, possibly due to absorption of proteins to the membrane surface.
By the Centriprep method non-protein components were also concentrated.
Electrophoretic analyses revealed that a 2u-globulin obtained by precipitation was
more pure than that prepared by the Centriprep method.
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Isolation and purification studies (II)
Efforts were made to elaborate a sufficiently powerful isolation and purification
method which was applicable for proteins in urine. High resolving
chromatographic methods are important for successful isolation of proteins with
similar properties. Hydroxyapatite concentrated rat urinary proteins were purified
by gel filtration and ion exchange chromatography. Electrophoretic studies by
SDS-PAG of samples from the two major peaks in the gel filtration chromatogram
resulted in similar molecular weights for the two protein fractions of 20 000 and
18 000, respectively. The gel filtration column used is particularly suitable for
separation of low molecular weight proteins. Determination by mass spectrometry
demonstrated that the proteins had molecular masses between 18 500 and 18 700
Da. In the gel filtration chromatogram the A280 peak II was three times higher than
peak I. Wavelength scanning in a spectrophotometer of samples corresponding to
the two peaks also indicated that approximately three times more protein was
present in the fractions of peak II than of peak I. Separation by ion exchange
chromatography showed that the protein in the two fractions constituted charge
variants. To improve the ion exchange separation conditions further different
buffer systems were evaluated as well as another ultrafilter. The BA 83 filter
previously used before sample application on the anion-exchange column was
exchanged for the OE 66 filter (Schleicher & Schuell, Dassel, Germany) giving
much higher recovery (unpublished data).
Two different extracts, the HPHT-extract and rat urine concentrated through
YM-2 ultrafiltration, were studied by affinity chromatography. The coupling
efficiency of the monoclonal antibody, mAb(6) with specificity for rat urinary
allergens, to the AminoLink column was determined according to the instructions
of the manufacturer and calculated to be 65%. The two fractions containing the
immunosorbent purified proteins were studied by Phast SDS-PAGE followed by
silverstaining. Two dominating proteins in the region between 14 400 and 20 100
could be seen and obviously the two isoallergens coeluted, i.e. mAb(6) thus
recognized and bound both proteins (148) and unpublished results). Similar
results were obtained by Western blotting utilizing biotinylated mAb(6) (148). On
the other hand the antibody mAb(1) with specificity for rat urinary allergen bound
only one protein. There was also a minor contamination of a protein with a size
similar to that of albumin, 67 000, as revealed by Phast SDS-PAGE. When the
fractions were separated in a gradient gel, 10-20%, no band at 67 000 could be
seen, indicating that this was most likely a contamination in that particular Phast
electrophoresis run.
Identification and characterization of certain proteins (II, V)
Amino acid composition and sequence analysis conclusively showed that the two
proteins corresponding to the two major peaks in the gel filtration chromatogram
were closely related and actually different forms of the same parent protein, a 2u-
globulin. Peptide mapping after enzymatic digestion of these two allergens
revealed two different peptide maps (V), which clearly verified our findings of the
different isoforms of a 2u-globulin. Subsequent amino acid sequencing of the
proteolytic fragments confirmed the close relationship. It was further
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demonstrated that the protein previously named pre-albumin is not transthyretin,
which is a completely different protein with certain well described properties (44).
Isoelectric focusing of the two isoproteins on Phast gels showed that the
isoelectric points were 4.55 for the allergen Rat n 1.01 (earlier called pre-albumin)
and 5.2 for the allergen Rat n 1.02 ( a 2u-globulin), respectively (unpublished data).
Rat urinary albumin and transferrin in the high molecular weight fraction seen
after gel filtration were identified by zone immunoelectrophoresis assay (ZIA).
Sets of 20 glass capillaries filled with agarose gel solution containing specific
antibodies against rat transferrin and albumin were used. Narrow
immunoprecipitates with sharp zone fronts were produced with migration
distances directly proportional to the concentration of the respective proteins. This
phenomenon can be used for their quantification. Changes in the transferrin
concentration in unprocessed rat urine related to the age of the male rats were also
studied by ZIA. The highest concentration of transferrin was obtained in the urine
of the oldest rats, and the night-time urine contained a higher concentration of
transferrin than day-time urine (unpublished data).
The allergenic potency of the two isoproteins was confirmed by strong skin
prick test reactions in patients allergic to laboratory animals. Rat n 1.01 seemed to
be slightly more reactive than Rat n 1.02. In contrast to the reported dot blot
results (IV) the response with the further purified rat albumin was weak.
Search for carbohydrate moieties in the glycoproteins immobilized on Western
blotting membranes indicated that the two main proteins in rat urine, in the
molecular weight range 18-20 kDa, were not glycosylated (unpublished data).
Direct glycostaining of SDS-polyacrylamide gels confirmed the results obtained
with Western blotting. No glycosylation of a 2u-globulin and its modified form,
previously termed pre-albumin, could be detected. However, with both these
methods two other rat urinary proteins were detected which were shown to be
most likely glycosylated. The 23 400 protein was revealed by Western blotting
and another protein with an approximate molecular weight of 40 000 by the direct
glycostaining procedure (unpublished data).
Quantification by chemiluminescence (III)
Modification and evaluation of the chemiluminescence detection method as well
as the luminometer previously described in (195) were performed. Here agarose
gel electrophoresis under non-reducing conditions followed by Western blotting
was used. The gray and black bands on the light sensitive film represent the
protein bands on the blotting membrane producing light signals due to the
chemiluminescence reaction. A good quantitative and linear relationship was
achieved for the IgE 150 kDa protein band over the concentration range of 0.01 to
0.6 IU IgE and the relative light units (RLU) measured. Each position on the
blotting membrane was measured for only 1.0 second in the luminometer
apparatus. Equally comparable detection limits and linear relationships between
the concentration of the antibody enzyme complex and RLU measured were
obtained for dot blots as well. Both a single and a double antibody system, goat
anti-human-IgE AP or rabbit-anti-human-IgE plus goat anti-rabbit-IgG AP,
respectively, were found to have similar sensitivity. However, the double antibody
system tended to give higher background probably due to extra incubation steps.
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Quantitative relationships for measured signal intensity, RLU, and the amount of
rat urinary proteins were obtained. However, due to the varying avidities of the
IgE molecules of individual sera the measured RLU values for a certain urinary
protein are not directly comparable. Also here a good quantitative and linear
relationship over the concentration range of 0.02 to 0.6 IU IgE was achieved for
the IgE band, 150 000, and the RLU measured.
Studies of non-denatured allergens by the dot blot technique revealed feeble IgE
binding to the proteins except for the albumin fraction which did bind IgE
antibodies relatively strongly. Even with proteins concentrated by membrane
centrifugation the binding was weak. On the other hand the HPHT-extract
displayed strong IgE antibody binding even when diluted 100-fold. Non-
concentrated rat serum albumin (Nordic), Soluprick (ALK) diluted 1:100,
nondialyzed and dialyzed unconcentrated fertile male rat urine responded
positively in the dot blot assay. Weak IgE antibody binding to the concentrated
protein fractions was seen in Western blotting. Our results indicate that dot blot
maintains more of the native protein conformation, which favors IgE binding.
Furthermore, it was found that repeated thawing and freezing of the samples
reduced their antibody binding capacity.
Three chemiluminescence substrates were tried. With CDP-Star 10 times
stronger light signals were obtained, allowing shorter film exposure times.
In the dot blot assay no specific IgG binding to the rat urinary proteins
separated by liquid chromatography could be seen despite the high abundance of
total IgG as compared to IgE.
Furthermore, in dot blotting, sera from rat-allergic patients showed IgE
antibody binding to proteins in saliva from atropinized and electrically stimulated
rat salivary glands. In contrast the proteins in saliva from non-atropinized and
non-stimulated rats displayed almost no antibody binding (unpublished results).
Epitope mapping (V)
To investigate if certain regions of a 2u-globulin preferentially might be involved in
IgE binding, sera from rat-allergic donors were assayed using overlapping
synthetic peptides representing the a 2u-globulin amino acid sequence. Generally
low absorbance values, representing specific IgE antibody binding, were obtained
with the individual peptides. Only a few peptides were more frequently
recognized by the IgE antibodies than others. After correction for the net
absorbance of the synthetic peptides, an arbitrary cut-off of OD 0.05 was used to
sift out the antibody binding peptides. By this criterion peptides no. 4, 7, 11, 15,
24, 32, 36, and 38 showed reactivity with 5 to 7 of the 15 sera studied. Likewise
peptides 13, 22, and 34 were not recognized by any of the sera (Fig. 6). The
specificity of the IgE reactivity was confirmed by inhibition studies using a
concentrated rat urinary protein extract.
Also the IgG binding to the overlapping peptides was analyzed for a few sera
from both allergic and non-allergic individuals but no specific pattern could be
seen due to considerable variation in the individual sera.
B-cell epitope prediction analysis indicated that the most probable epitope
region in the protein sequence is between the amino acids 50 and 102, which
corresponds to the synthetic peptides no. 8-20.
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4. Discussion
Allergic reactions are complex, multifactorial processes. Knowledge about the
biochemical and biological properties of allergenic proteins are of importance for
the understanding of allergic diseases. Certain features might predispose proteins
to become allergenic. Such information could be helpful when trying to
understand the underlying causes of the progressive increase of allergic diseases.
Early identification of persons at high risk of developing allergy is essential for
prevention. For therapeutic purposes immunotheraphy forms, with low risk-to-
benefit ratio which not cause anaphylactic reactions, are desirable. In this context
well characterized allergenic proteins are an advantage. Accordingly, the
isolation, identification and characterization of the two closely related potent
allergenic a 2u-globulin proteins corresponding to the allergens Rat n 1.01 and Rat
n 1.02, which this thesis is focused on, is hoped to contribute to the understanding
of laboratory animal allergy, LAA.
Urine sampling
Collection and handling of the raw material prior to purification could influence
the properties of the urinary proteins and their subsequent identification and
characterization. Thus, two different collection methods were studied; in
metabolic cages and by bladder puncture. In addition two different sampling
modes, day- and night-time urine, were studied. It was decided not to use
preservatives and enzyme inhibitors, as this would more closely mimic normal
conditions in experimental animal housing. Differences in the protein composition
of the various types of urine samples were analyzed by electrophoresis and
subsequent silverstaining. Each sample was shown to contain numerous separated
protein bands as has been shown previously (78). There was variability among the
samples with respect to the number of bands and the amount of protein in the
bands. Both the contents and the relative distribution of protein in the bands were
partly influenced by the collection method and partly by the time of sampling.
Prolonged storage of urine in room temperature for 72 h seemed only to have
effect on the night-time collected urine. Some bladder specific proteins of low
molecular weight were not found in the night-time urine. These proteins are
obviously particularly sensitive to different kinds of degradation upon exposure to
air, which is what normally occurs in the cages. The reasons for these
discrepancies between day- and night-time urine could be that night-time urine
was collected for 18 h whereas day-time urine was collected during 6 h. Thus, the
night-time urine could have been exposed to hydrolytic enzymes for a much
longer period. The urine collected by bladder puncture had protein patterns
somewhat different from urine samples collected in the cages.
The electrophoretic protein patterns of urine stored for a long time at -70 ° C was
somewhat altered as compared to that of fresh rat urine sampled in the same way.
Thus, for aged urine as well as for long-term stored urinary protein fractions an
occasional partial displacement of proteins towards lower molecular weights was
27
seen (unpublished data). Possibly this was due to enzymatic degradation.
However, it was not within the scope of this study to examine in greater detail
whether the differences seen were caused by oxidation, proteolysis by enzymes
originally present in the urine, or by microbial growth.
Concentration of proteins
Two different concentration methods were used: One chromatographic procedure
utilizing hydroxyapatite (paper II) and an ultrafiltration method using Centriprep
(paper I). The Centriprep method was rapid but gave incomplete recovery, and
non-protein components were as well concentrated by this method. It should also
be mentioned that precipitated a 2u-globulin is more pure than that obtained by
Centriprep concentration.
Chromatographic concentration on hydroxyapatite is both fast and gentle (78)
and can be used for labile proteins (38). Hydroxyapatite has a high adsorbing
capacity for proteins and accumulation of non-protein substances naturally
occuring in urine is avoided. Thus, the hydroxyapatite method was milder, and
contamination and denaturation of the urinary proteins was avoided to a greater
extent; therefore this concentration method was preferred.
Purification
There are several reports describing purification of a 2u-globulin using various
chromatographic methods (89, 94, 95, 105, 192). Nevertheless, these separation
techniques were found not enough high resolving for the isolation of a 2u-globulin.
Therefore, another strategy was selected where hydroxyapatite-concentrated rat
urinary proteins were purified by gel filtration and ion exchange chromatography
using the FPLC system (paper II). In a previous study this separation procedure
had been shown useful (78). The chromatogram of the gel filtration separation
showed two major peaks, which were separable despite quite similar molecular
protein masses. This might be due to different conformations of the proteins. Ion-
exchange chromatography as well as isoelectric focusing revealed that there were
charge variants or mixtures of closely related proteins. These minute differences
between proteins could be caused by amino-acid microheterogeneity or C-
terminal differences, or by point mutations that resulted in exchange of a few
amino acids. The anion-exchange chromatography technique was further
improved by modifying the buffer system and by the use of another type of
ultrafilter prior to sample application on the Mono Q column.
Later an affinity chromatography method was tried, which used an AminoLink
column and a mouse monoclonal antibody specific against rat urinary allergen,
Rat n 1 (148). However, this immunosorbent technique did not separate the two
isoallergens, Rat n 1.01 and Rat n 1.02 (148 and unpublished data), since the
monoclonal mAb(6) specific against rat urinary allergen Rat n 1, used was shown
to recognize both proteins. Rat n 1.01 and Rat n 1.02 correspond to the two
isoproteins described above which were fractionated by liquid chromatography.
The preferred method for purification of rat urinary allergens utilize the unique
concept of the FPLC system which comprise high performance chromatography at
low pressure for the separation of biologically active molecules. In conclusion,
28
high resolving chromatographic methods are needed for isolation of isoallergens
and proteins with similar properties. This purification procedure should also be
suitable for allergens from other sources.
Electrophoretic studies
Electrophoresis is a valuable tool for identification of proteins with regard to size
and charge irrespective of sample origin. Analysis by electrophoresis is
particularly suitable for complex samples such as urine. The purification
procedure was monitored by electrophoretic methods and the proteins in the
chromatographic fractions were analyzed with respect to isoelectric point (pI) by
isoelectric focusing (IEF) and relative molecular mass (Mr) by sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) under reduced and non-
reduced conditions. In IEF, horizontal gels with the respective pH-gradients 3-9
and 4-6.5 (Phast-system) were used. The pI value obtained for the allergen Rat n
1.01 (4.55) is in agreement with previous studies (105, 106). The pI-value for Rat
n 1.02 was slightly more acidic (5.2) than earlier reported by Longbottom (5.4, 5.6
and 5.8, as presented in different publications). The calculated pI for Rat n 1.02 is
5.48 (Swissprot, release 35). Here it should be mentioned that the pI value of a
specific protein is influenced by certain experimental parameters. Thus when
measurements are carried out at 4 ° C a value about 0.5 pH units higher than at
25° C may be obtained (197). Therefore fairly large discrepancies are to be
expected, unless the conditions in the investigations compared are quite similar.
Furthermore, to get good agreement between experimentally determined and
calculated pI values the computer program used must be able to handle all
parameters correctly.
In the SDS-PAGE, commercially avaliable horizontal gels or vertical gel slabs
made in our laboratory were used with a linear gel gradient of increasing
acrylamide concentration and hence decreasing pore size. A gradient gel is most
suitable for complex mixtures, as it gives higher resolution and sharper individual
bands than homogeneous gels (113). In this study non-reducing conditions means
the absence of 2-mercaptoethanol, which reduces the disulphide bonds in proteins,
resulting in incomplete denaturation and binding of fewer SDS molecules to the
polypeptide (9). Compared to the anionic detergent SDS, non-ionic detergents like
Triton X-100 preserve the immunological activity and the native structure of the
protein better because the protein is not disrupted into subunits (9).
Different molecular weight values are usually obtained in SDS-PAG in the
presence and absence of reducing agents. In the presence of reducing agents large
amounts of the anionic detergent SDS are bound to the protein molecules resulting
in dissociation into subunits. With large amounts of charged detergent molecules
the net charge of each protein molecule per unit mass becomes approximately
constant. The electrophoretic migration in the acrylamide gels is then proportional
to the molecular weight of the protein. For proteins containing intra-disulphide
bonds the absence of reducing agents results in incomplete unfolding of the
polypeptide chain and thereby less binding of SDS molecules (9). This leads to
changed migration of the protein in acrylamide gels. The positions of protein
bands in such gels were different when reduced and non-reduced sample
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preparations of the same protein were compared. The non-reduced samples
showed protein bands with increased electrophoretic mobility having moved
further down the gel. This could be misinterpreted as decreased Mr. Moreover, the
extra bands that appeared in the reduced samples are probably due to oxidation
products of the reducing agent (174) and/or dissociation of the proteins into
subunits (9).
Identification and molecular characterization
Throughout the purification steps, fractions and samples were analyzed with
various electrophoretic methods. ZIA (194) was used to identify albumin and
transferrin in the high molecular mass protein fraction eluted from the Hiload
column. One advantage of this immunoprecipitation method is that large and
varying sample volumes can be used. The method is also quite insensitive to
variations in the molecular conformation and aggregation states of proteins. The
age dependent increase in the excreation of urine proteins seen for the transferrin
concentration is in accordance with the excretion of both total urinary proteins and
a 2u-globulin as reported by Neuhaus (128). The results obtained concerning the
protein concentration in the day- and night-time urine as well as the transferrin
contents measured by ZIA corroborate with those reported in another study by
Neuhaus of the circadian rhythm of protein excretion (127).
Amino-acid compositional and sequence analysis followed by mass
spectrometric determination were used for identification and characterization of
the purified proteins described in Paper II. The results showed that the allergenic
rat urinary protein denoted pre-albumin is not the same as the well characterized
protein transthyretin (44) which has been thoroughly studied in blood samples.
We have shown that this "non-transthyretin" protein and a 2-euglobulin are
different forms of the same protein, a 2u-globulin. Our findings have bearing on the
modern allergen nomenclature for these two proteins called Rat n 1.01 and Rat n
1.02, respectively (170, 171). Correct identification, characterization and
nomenclature of individual allergens are important especially to avoid mistakes
and misunderstanding. Multiple isoforms of a 2u-globulin have been described to
occur in various tissues (27, 70, 110, 151, 205). Hormonal, developmental (70), or
age-dependent regulations (126, 151) have been suggested to explain these
variations of a 2u-globulin expression.
Glycosylation
Glycosylation of a protein may be of significance for its antigenic properties and
contribute to immunogenicity (172). Many allergens share characteristics
displayed by viral and bacterial proteins to which the body has developed non-
adaptive defence mechanisms. Macrophages possess a variety of different
receptors, for example carbohydrate receptors (119). Thus, binding of the
carbohydrate moiety of the glycoprotein to the receptor results in endocytosis
followed by the release of mediators (172), which might lead to the development
of hypersensitivity reactions. The carbohydrate binding receptors are important in
host defence, particularly in the removal of bacteria (172). In this regard, the
possible existence of glycosylated forms of a 2u-globulin was studied in some
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detail. According to the Swissprot database, release 35, there is a possible
glycosylation site at the position 54, asparagine (Asn) in the full length protein of
a 2u-globulin. Essential for the N-glycosylation is the tripeptide Asn-X-Thr/Ser,
where X is any amino acid except proline (64, 114). Glycosylation is inhibited by
proline residues in position X and in the position next to Thr/Ser (64). A site
lacking proline residues in these two positions has been estimated to be
glycosylated in 93% of the cases studied (64). The putative proline free
glycosylation site in a 2u-globulin is the four amino acid long peptide sequence
Asn-Gly-Ser-Met. Folding/unfolding of the protein is also suggested to be
important in the regulation of the N-glycosylation (141). Exposure to the
carbohydrate-transferring enzyme, oligosaccharryl transferase, which is found in
the lumen of the endoplasmic reticulum, may also be of significance (64, 84, 99).
No evidence for glycosylation of the two main proteins in rat urine was
obtained from Western blotting or direct glycostaining after SDS-PAGE
(unpublished data).
It has been suggested that the carbohydrate content in a 2u-globulin could be
caused by unsuccessful cleavage of sugar residues prior to secretion of the protein
from the liver (36, 93). Two glycosylated derivatives with the molecular weights
21.2 and 20.6 kDa have been described (36) as well as two non-glycosylated
forms of the processed protein (18.8 kDa and 18.1 kDa) initially synthesized as
two unprocessed forms containing a 19 amino acid signal sequence which is
cleaved off prior to secretion (27). Other investigators  have suggested that there
are three forms of a 2u-globulin in rat hepatocytes of which two are glycosylated,
one with the molecular weight 75 kDa and another of 50 kDa (72). Female rats do
not synthesize the non-glycosylated form of the 20 kDa a 2u-globulin protein (152,
192). No real evidence for the existence of two glycosylated high molecular
weight forms of a 2u-globulin was obtained by us although two forms were
reported by Haars and Pitot (see ref. 72).  In contrast, we have indications
supporting the presence of the two glycosylated unprocessed forms, 20.6 and 21.2
kDa, in both concentrated and untreated rat urine which is in agreement with
results of Chatterjee et al (see ref 36).
Quantification of proteins by chemiluminescence
Sensitive measurements of proteins blotted on membranes after Western blotting
as well as after dot blotting were performed by chemiluminescence. A specially
built luminometer was used. This instrument can be utilized for measurements
directly on blotting membranes, in microtiter plates and test tubes (195). The
chemiluminescence detection method and the newly developed luminometer were
modified and evaluated (paper III). For evaluation of proteins separated by SDS
agarose gel electrophoresis, non-reducing conditions were used to maintain the
biological activity of the proteins. Agarose gel has a more open pore structure and
is thus preferable to polyacrylamide gel for studies of large proteins such as IgE of
150 kDa. More protein can be applied per lane in agarose gels as compared to
polyacrylamide gels, due to a lower risk of clogging the gel pores.
Major advantages of the chemiluminescence detection methods are that they do
not require use of radioactive isotopes and still have very low detection limits and
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wide measuring ranges. Further, the fact that the light signals are stable and are
emitted for hours allows multiple measurements on a membrane. Permanent
records of the blotting results can be generated by capturing the emitted light
directly on film with the possibility of repeated film exposures. In addition, the
luminescence reagent can be washed off and the membrane can be probed again
with the substrate. This second probing gives almost equally good light signals.
The membrane can also be processed to expose precipitated stained enzymatic
products after the luminescence reaction (3).
The detection level for the IgE band in the immunoblotting membrane after
agarose gel electrophoresis (paper III) was lower, 0.005 IU, than in the PVDF
membrane after SDS-PAGE (paper IV), 0.02 IU. This could be explained by the
more open pore structure in the agarose gel. Transfer of larger proteins to a
membrane is more complete from agarose gels than from polyacrylamide gels
(19). Thus, since some of the IgE molecules remain in the polyacrylamide gel this
might result in a lower detection limit when this gel type is used.
The risk of contamination with phosphatase activity of microbial origin must be
eliminated by the use of fresh and sterile filtered solutions as well as ethanol
washed incubation trays and properly cleaned GelBond. It is important that the
enzyme is saturated with substrate in order to obtain light signals proportional to
the amount of enzyme. The white areas occasionally seen in films in the center of
the dots or the bands could be due to too high concentration of the protein. When
there is too much protein, large amounts of antibody-conjugated alkaline
phosphatase are bound resulting in rapid dephosphorylation of the
chemiluminescent substrate so that less light emission is seen after a while. The
intensity of the signal then begins to decay shortly after substrate application,
resulting in an underexposed area on the photographic film. To avoid this the
amounts of protein at each position studied should be limited. Therefore we have
examined various protein loads per lane in the electrophoresis gels as well as at
dot blotting.
Allergenicity studies of rat urinary proteins
Western blotting is often used to study separation of protein antigens present in
complex mixtures such as rat urine, and also for their identification and comparison
without prior isolation and purification. In addition to physicochemical
characteristics such as Mr and pI of IgE-binding proteins, blotting provides
important information on the occurrence and intensity of IgE antibody binding to
allergens. Human IgE binding components in rat urine were thus studied by
immunoblotting (paper IV). Non-reducing conditions were chosen to preserve the
allergenic activity and because non-reduced proteins were shown to be transferred
more easily to the blotting membrane than under reducing conditions. Individual
IgE-binding patterns, reactivity profiles, were obtained and investigated in sera
from rat-sensitive persons. The variability in the profiles seen in paper IV is
probably due to different avidity of the antibodies which in turn may depend on the
individual’s different exposure or boostering to the allergens. Another factor which
might influence the immune response to specific allergens is the genetic
predisposition of the subjects (26).
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Minor components which would not be visualized when using a serum pool
could be detected when using individual sera. It should be noted that IgE
antibodies from some patients were almost entirely directed against such urinary
proteins with molecular weights below 35 kDa, of which there are only small
amounts in rat urine. The binding profiles, exhibiting reactivity with both the low
molecular weight constituent in the 20 kDa range as well as the albumin area, are
in agreement with observations made by others (67, 77). Hollander et al (77)
obtained the strongest reaction with the 15, 24, and 66 kDa proteins, while
Gordon et al (67) observed the most prominant IgE-binding to the 17, 21, 23, 63,
and 68 kDa proteins. The differences between the reactivity profiles seen in the
three studies may reflect not only the above mentioned conditions but also
variations in the methodologies, in the origin or preparation of the proteins. For
instance, different rat strains were used which varied slightly in age. Sprague
Dawley rats 15 weeks old were used in our study and Wistar rats 12 weeks old in
the study by Gordon et al (67). In the study by Hollander et al (77) Wistar rats
were used. This could be of some significance, since it is known that there may be
species variations in the expression of urinary proteins (73). In addition, the
sample preparations and analysis conditions were not exactly the same in the three
studies. In our study and in the study by Gordon et al (67) non-reducing
conditions were used, whereas in the study by Hollander et al (77) reducing
conditions were utilized, which would most likely influence the reactivity patterns
due to altered electrophoretic mobility of the proteins as discussed above. Further,
the visualization systems used in these studies were different as well as the
antibodies used for detection.
All patients in our study had IgE binding to Rat n 1.02, some more pronounced
than others. However, the detection signal was relatively weak for purified Rat n
1.01 and Rat n 1.02, even after concentration by membrane centrifugation, in both
Western blotting and the non-denaturating procedures using dot blot or line blot.
The low detection signals could be due to losses by adsorption of the proteins to
the walls of the vessels used for storage (glass/plastic) (111). This problem can be
more pronounced at low protein concentration. Another possible cause for the
weak signal is that some IgE-binding epitopes may be non-accessible for the IgE
antibodies when the protein is bound to the membrane. In addition, transfer from
the gel to the blotting membrane is not always quantitative (180) and thus some
proteins will not be completely transferred. The agent used to block antigen
binding sites in the membranes could also influence the detection of IgE-binding
components, particularly those of low Mr. Blocking with Tween-20 would allow
the detection of proteins with low Mr (180). In our studies gelatin was used for
blocking, giving relatively low background and reduced the artefactual non-
specific antibody binding. Loss of antigenicity due to conformational changes
during the purification (17) could be another reason for low detection signals. This
was evidenced by the weaker IgE antibody binding to the purified antigenic
proteins compared to the corresponding native proteins present in the rat urine
extract when analyzed by Western blotting. Furthermore, during the sample
preparation before electrophoresis the proteins are exposed to heating and
denaturation which will destroy their tertiary conformations; the proteins open out
into linear forms that might only partly refold again in the PVDF membrane.
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However, allergens have been reported to be multivalent and the IgE antibody
response to them is probably polyclonal which means there is a good chance that
sufficient determinants on the antigen molecules can survive the denaturing
conditions to allow detection of each allergen under dissociating conditions (181).
Another problem could be the presence of mainly low affinity IgE antibodies.
Such antibodies may be lost during washing of the membrane resulting in weak
detection signal. The varying avidities of the IgE molecules in individual sera as
well as the quality of the secondary antibody are also important parameters. Anti-
IgE antibodies used for detection but of lower specificity might result in
unspecific binding and the appearance of bands in the PVDF membrane even with
negative control sera due to unspecific binding.
When the Rat n 1.01 and Rat n 1.02 were used in skin prick tests strong
reactions were obtained confirming earlier studies (78). In vivo tests are generally
considered to be more sensitive than in vitro tests (189) but they rely on
completely different mechanisms. Therefore they do not necessarily give
concordant results. Thus, even though the reliability of these in vivo and in vitro
methods is generally good, it is sometimes difficult to make an accurate allergic
diagnosis by using only measurement of allergen-specific IgE concentrations. For
example, low values of specific IgE do not necessarily imply that the patient is
non-allergic. In sera from some rat allergic individuals a significant specific IgE-
binding in Western blotting was observed despite low RAST values (unpublished
data). In conclusion, Western blotting is an important tool for allergenicity studies
of proteins. The method gives a good general view of the strongly varying
individual IgE-binding patterns in sera from rat allergic patients regarding both
distribution and intensity of the reactivity for different proteins.
IgE binding proteins in rat saliva
In dot blot studies sera from rat allergic patients showed positive reaction with rat
saliva, indicating presence of allergenic components. It may be mentioned that
a 2u-globulin has been reported by others to be present in rat saliva (62).
Stability of allergenic proteins
Compared to other proteins most allergenic proteins are relatively resistant to
enzymatic attack and chemical denaturation. The suggested reason for this is that
these mostly environmental components are naturally subjected to degradation
processes and thereby may resist host defence mechanisms more effectively (45,
176). Moreover, many of the food allergens, which are often storage proteins in
plants, having molecular weights ranging between 10 and 70 kDa, are often stable
molecules resistant to processing, cooking and digestion (98). Within the lipocalin
family the conserved tertiary structure, the eight-stranded b- barrel conformation,
forms a compact protease-resistant framework (137). Further, a 2u-globulin is
classified as a stable protein according to a computed instability index (71). The
stability may allow these allergenic proteins to persist in various environments for
comparatively longer times. On the other hand, allergens in aqueous extracts
sometimes show limited stability upon storage. In this case the stability can be
improved by lyophilization or addition of 50% glycerol (45). In addition, storage
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of proteins at neutral pH may result in isoaspartic acid formation causing
modification or loss of certain properties of the protein (204). Decreased stability
of an allergen extract might involve loss of allergenic activity, which perhaps
could explain the relativly low IgE-antibody binding obtained with the purified
allergens in Western blotting and in dot blot assay.
Repeated thawing and freezing of the sample may also affect the binding of
antigens with murine monoclonal antibodies (148) as well as human IgE
antibodies (paper V and unpublished data). Storage of allergen extracts can
sometimes influence the detection of the allergens with monoclonal antibodies
(148). This is probably due to break down of proteins examined during storage as
discussed above.
Human exposure to allergenic rat urinary proteins involves both the native
proteins in the urine directly after excretion and proteins that have been more or
less modified due to oxidation or microbial activity when urine dries and ages.
However, as shown in paper I, electrophoretic studies of urine before and after
special treatment (i.e. prolonged incubation at room temperature) showed that
these treatments seemed to have minor effects on the protein composition. In
addition, others (147) using mouse monoclonal antibodies specific against rat
urinary allergen, Rat n 1, have recently shown that there is only a marginal effect
on the detection of allergenic rat urinary proteins subjected to accelerated
degradation (87). The purpose of accelerated degradation was to mimic what
might happen with proteins in excreted urine in animal houses keeping rats.
Epitope mapping
In this study we investigated in some detail IgE binding determinants of a 2u-
globulin, Rat n 1.02. Overlapping peptides of Rat n 1.02 were synthesized on solid
support and screened by a modified ELISA procedure (paper V). There are several
advantages with synthesized peptides. For instance, they can be produced
reproducibly in large amounts and thus offer more reliable and controllable results
than peptide fragments obtained by enzymatic digestion of native and purified
protein.
Sera from individuals who were allergic to rats were tested. Two possible IgE
binding regions were identified: one located in the N-terminal and one in the C-
terminal part of the protein, respectively. The N-terminal region involved peptides
4 and 7 and the C-terminus peptides 32, 36, and 38. However, relatively weak IgE
binding with the synthetic octapeptides was seen as compared to the results
obtained with the native whole protein molecules of a 2u-globulin in direct ELISA.
This observation indicates that allergen specific IgE molecules mainly recognize
conformational epitopes and to a lesser extent primary sequences. If the synthetic
fragment only constitutes a portion of the correct epitope this will cause weak IgE
binding (181). In the full length protein this might be overcome since it contains
several antigenic determinants to which the antibody could bind. The results also
indicate that the IgE antibodies are directed to native Rat n 1.02 and, therefore,
may bind less strongly to the unfolded protein. Another suggestion would be a
quenched activity signal due to relatively high background reactions resulting
mainly from cross-reacting antibodies as well as different exposure histories in the
allergic individuals (35).
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Other studies have shown low IgE binding to synthetic peptides of allergens
like cat major allergen, Fel d 1, (190). Nevertheless, synthetic peptides have been
used by many scientists to determine IgE epitopes in several allergens (15, 16, 52,
53, 118, 201).
Even though the peptides probably represent only parts of a more complex
discontinuous epitope (as is the case for the vast majority found in proteins) these
linear fragments may have characteristic conformational features resembling those
of the closely related structures in the parent protein and, therefore, it is relevant
to identify them. Furthermore, a suitable IgE binding conformation may be
formed in the peptide when it binds to the antibody paratope (138). However, T
cell epitopes should also be studied to confirm useful and relevant allergen
specific epitopes for immunotheraphy as discussed below.
Another theoretical explanation for the low seroreactivity of the synthetic
peptides could be that the IgE epitopes might be blocked by IgG antibodies due to
their higher abundance in serum as compared to the IgE antibodies.
Homology studies
Comparisons of amino acid sequences in a homology search with the BLAST
program revealed 59 homologies, most of them from mammalian species (paper
V). Several of them were recognized as allergens, for instance, bovine major
dander allergen (Bos d 2), mouse major urinary protein (Mus m 1), horse allergen
(Equ c 1) and dog allergen (Can f 2). Allergenicity might be a general property
shared by a group of lipocalins with one or several epitopes in common. This is an
interesting notion which ought to be investigated in more detail.
Three-dimensional protein profile analysis has been proven to be useful for
homology modelling (29). This profile-search technique has been applied to
lipocalins and related proteins and the results suggest that there are two distinct
lipocalin sub-families (156), one that corresponds to e-RABP (epididymal retinoic
acid binding protein) and the other comprising, among other proteins, A2U ( a 2u-
globulin) as well as MUP (mouse urinary protein). By profile searching a total of
70 lipocalins and 15 related non-lipocalin proteins were shown to have the
characteristic lipocalin fold (156). Since the sequence homology within the
lipocalin family on the average is only about 20% (60) the BLAST program
search resulted in fewer lipocalin members than other investigators have found by
3-D searching (156).
In contrast, the structural homology is greater. The lipocalins have a
phylogenetically conserved structure with an eight-stranded b -barrel conformation
which is lined with hydrophobic side chains containing aromatic residues (27, 34,
66, 206). The composition of the side chains differs between the proteins in the
a 2u-globulin superfamily and thereby determines their ligand specificity (27). In
a 2u-globulin the pocket is formed by the amino acids 59, 73, 75, 109, 122, 137,
and 139 (using the numbering in the SWISS-PROT Protein Sequence Database)
(34). The residues in the a 2u-globulin protein which form the base of the binding
site for the natural ligand are Phe 73, 109 and 122 (34, 81) which noncovalently
can bind lipophilic compounds, for example metabolites of compounds present in
unleaded gasoline (175). Although the binding site of a 2u-globulin has been
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studied (81) the natural ligands have not yet been identified. The conserved
folding pattern contains three characteristic sequence forms, so-called motifs,
corresponding to the three largest structurally conserved regions (60). Motifs 1
and 2 lie close to each other in the three-dimensional structure, and they are also
near the surface of the protein (132) and thereby they most likely constitute a
binding site. The residues Phe 109 and 122 seem to be located in motif 2 but Phe
73 is not located in any of the three motifs. Further, the IgE binding synthetic
peptides 4 and 7, corresponding to the N-terminus amino acids no. 33 - 40 and 45
- 52, respectively, in the a 2u-globulin protein, would probably be located within
motif 1. In the C-terminus part of the protein sequence peptide 32, corresponding
to amino acids no. 145 - 152, might be located within motif 3. Peptide 22 (amino
acids no. 105 - 112), not recognized by any of the sera tested according to the
criteria used here to define an IgE binding peptide, could partly be located in
motif 2. Also peptide 15, amino acids no. 77 - 84, appeared to be located near this
cavity. However, the IgE binding to the peptides corresponding to these three
motifs was relativly low in sera of most of the individuals studied. Further
investigations are required to define if the IgE binding regions found in this study
could be located close to this pocket in the tertiary structure. In this connection
structure comparison of a certain protein antigen with known allergens and their
allergenic epitopes could be worth further studies.
The alignment GXW, where X is usually an acidic amino acid, is a key
sequence conserved in most lipocalins (163). In a 2u-globulin this sequence is
assigned to GDW and most likely located within motif 1 (60), i.e. the amino acid
positions 36-38.
Binding of different substances such as metabolites of fuel and solvent derived
hydrocarbons, various chemicals or pheromones could induce structural
alterations of the protein (27, 34, 96, 134). Due to this conformational changes
owing to the ligand binding new epitopes may be exposed or some epitopes may
even be concealed. This could affect the recognition by human immunocompetent
cells or antibodies. However, ligand studies were not within the scope of this
thesis.
Future aspects and significance of the studies in relation to diagnosis of
allergy and immunotherapy
Enhanced production of the cytokines IL-4 and IL-13 by allergen-specific T cells
is responsible for increased IgE synthesis and the development of allergic diseases
(41) which affect a large proportion of the individuals in a population. There are
several mechanisms by which allergic symptoms are believed to be reduced. It is
believed that this could be achieved by diminishing the production of Th1 and
Th2 cytokines or forcing the Th2 response towards a Th1 response (88).
Desensitization involving repeated low-dose subcutaneous injections of
standardized allergen extracts has been shown to induce a temporary tolerance to
normal allergen doses in some allergic individuals (28). This might be due to a
shift towards IgG production (28). The IgG antibodies bind to the allergen,
forming a complex which could be removed by phagocytosis, and the allergen is
thus no longer available for the IgE antibodies. A major drawback of this
procedure is that in the allergen extracts commercially available the content and
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relative abundance of individual proteins, i.e. the antigen composition, can vary
markedly both between manufacturers and between batches from the same
manufacturer (180, 185). Careful physicochemical and immunological
characterization of the proteins in such extracts would therefore be helpful for
standardization, as has been pointed out by others (45, 191). In this context, the
use of recombinant proteins offers an alternative for therapy and diagnosis of
allergic diseases (88, 185). Large quantities of well-defined recombinant allergens
can be produced using DNA-technology (157). This implies more reliable
diagnosis and safer treatment. However, one disadvantage with the use of
recombinant allergens is that the IgE-binding could be less than for their natural
counterparts (30, 56, 57, 184, 187). Allergy diagnosis has been performed with
various recombinant proteins, such as grass and tree-pollen allergens (91, 120,
136, 184, 186). Antibodies specific to a certain allergen in an extract could be
detected by using recombinant allergens which would be useful in determining
patients’ allergen profiles and when following treatment during the disease (88).
Also cross-reactivity of IgE for allergens in tree-pollen, fruit and vegetables has
been studied with recombinant proteins (48). Naturally occurring hypoallergenic
isoforms of allergens with no or very low IgE binding capacity but with a strong
T cell inducing response have been shown to be useful for immunotheraphy (56,
88). Production of such recombinant isoforms facilitates high dose treatment in
immunotheraphy. Another suggested approach for safe treatment is the use of
modulated variants of recombinantly produced allergens (88). By exchanging a
few single amino acids in the sequence of the major birch-pollen allergen, Bet v 1,
a variant with low IgE binding ability but with conserved T cells reactivity was
obtained (55).
It has been reported that gene vaccination could be useful as a variant of
allergen immunization (167, 179). In this technique plasmid DNA encoding an
allergen are used which induces a Th1 response (146). The advantage of this
technique is that it seems to be a safer form of immunotherapy since the allergens
are produced in the host’s cells and are mainly intracellular. Very little allergen is
secreted and thereby are risks of anaphylactic reactions diminished (150, 167).
This is the case in both rats and mice when immunized with plasmid DNA (166).
Immunotherapy is especially successful in younger patients with seasonal
allergy, who are sensitized to only a few allergens (125). In the search for a cure
or treatment of the allergic diseases, peptide immunotherapy might be useful.
Injecting synthetic peptides representing linear B-cell epitopes could be an
alternative when trying to induce tolerance in type I hypersensitive patients. Thus,
identification of low affinity IgE-binding epitopes yet with high T cell activating
capacity could become useful for immunotherapy. However, in our study (paper
V) only B-cell epitopes were studied. It is possible though, that the synthetic
peptides 13, 22, and 34 in the a 2u-globulin sequence, which were not recognized
by IgE antibodies in any of the sera from the rat allergic patients, might be
suitable candidates for immunotherapeutical treatment. However, the T-cell
stimulating ability of these peptides needs to be investigated in order to confirm
this possibility.
Immunotherapy has been shown to be successful in the treatment of bee venom
or yellow jacket venom allergies. Repeated injections of fragments from pepsin-
digested bee venom phospholipase A2 allergen into allergic patients have been
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shown to reduce allergen specific IgE and IgG antibody responses (104). In
addition, administration of peptides from pepsin-digested ragweed pollen extract
has been found to prevent seasonal increases in the concentration of ragweed
allergen specific IgE antibodies (103).
To conclude, detailed characterization of protein allergens will undoubtedly
become more important not only for diagnostic purposes - in vitro allergen tests
and standardization of extracts for prick test - but also for immunotherapy.
Particularly as the biochemical properties of allergenic proteins probably are of
importance for their processing at mucosal surfaces and how the immune system
responds to them. It is also possible that certain biochemical or biological
properties might predispose proteins to become allergenic especially since IgE
cross-reactivity with related as well as unrelated allergens has been observed (48,
168).
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Concluding remarks
The continuing increase in the prevalence of allergic diseases of both
environmental and occupational origin calls for extended studies of the nature of
allergens. Well characterized and purified allergens allow studies of various
aspects of allergy. Laboratory animal allergy (LAA) is classified as an
occupational disease. Exposure to rat urine is one of the most common causes of
LAA with symptoms such as rhinitis, conjuctivitis, urticaria and asthma.
This thesis deals mainly with the isolation, identification and characterization of
some potent allergenic proteins belived to contribute to better understanding of
allergic diseases and improved possibilities for diagnosis or treatment of allergies.
The following can be concluded:
The chromatographic procedures utilized for isolation and characterization of rat
urinary allergens can also be useful for allergens from other sources.
Chemiluminescence and the newly developed luminometer offer high sensitivity
and wide measuring ranges for proteins.
IgE binding regions of the major protein a 2u-globulin, corresponding to the
allergen Rat n 1.02, were identified using overlapping peptides spanning the
whole protein sequence.
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Summary
Bayard C. Purification, characterization and immunological studies of rat urinary
proteins causing allergy in humans; Arbete och Hälsa 1998:15. National Institute
for Working Life, Solna, Sweden.
Rats are among the most frequently used laboratory animals and rat allergy
constitutes a common occupational problem. Approximately 20-30% of the
personnel engaged in work with laboratory animals show symptoms of allergy.
These include rhinitis, conjunctivitis, urticaria and sometimes asthma, symptoms
which usually develop during the first three years of exposure. The allergic
reaction arises from direct contact with rat urine, or by exposure to airborne dusts
originating from dried animal urine. Rat urine contains a complex mixture of
proteins some of which are known to be allergenic, for example a 2u-globulin. In
urine from fertile male rats a 2u-globulin is one of the most abundant protein.
The primary aim of this thesis was to purify and identify the most potent
allergens in rat urine. Knowledge about the biochemical and biological properties
of allergenic proteins is of importance for the understanding of allergic diseases.
Consequently, two other aims of this thesis were to optimize various assays for
evaluation of the allergenicity of the identified allergens and to examine in some
detail the IgE binding regions of the major allergen, Rat n 1.02, a 2u-globulin.
Rat urinary proteins were separated and purified by ultrafiltration through
centrifugation and by chromatographic methods. The high resolving
chromatographic purification procedures used involve molecular size separation
by gel filtration followed by charge separation on an ion exchange column. The
two purified dominating proteins were identified as different forms of the same
parent protein, a 2u-globulin, by amino-acid compositional and sequence analysis
as well as mass spectrometry. Electrophoretic methods were also used to analyze
the proteins with respect to relative molecular mass by sodium dodecyl sulfate
polyacrylamide gel electrophoresis, and isoelectric point was determined by
isoelectric focusing. It was further proved that the urinary protein previously
named pre-albumin had no amino acid sequence resemblance to prealbumin
(transthyretin) present in rat serum. Additionally, the procedures reported here for
isolation and studies of allergens can be used for examination of allergens from
other sources.
The allergenicity of the rat urinary proteins was studied with Western blotting
using IgE antibodies in sera from allergic patients. A detection system utilizing
chemiluminescence and a luminometer apparatus gave scanning curves of IgE
binding and allowed arbitrary measurement of the amount of IgE bound to a
certain urine protein. Specific patterns of IgE binding to the electrophoretically
separated rat urinary proteins were shown for each individual. All allergic subjects
studied had IgE antibodies binding to the major urinary protein, a 2u-globulin. In
most of the sera examined the IgE antibodies specifically binding to a 2u-globulin
were more abundant than such binding to other proteins. However, this protein
was not always the most dominating allergen.
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Immunoblotting offered a good overview of the strongly varying individual IgE-
binding patterns seen in sera from rat allergic subjects regarding both distribution
and intensity of the binding.
Overlapping octapeptides corresponding to the amino acid sequence of the
major allergen Rat n 1.02 were synthesized on solid support and screened in
parallel to pinpoint the IgE-binding regions of the protein using a modified ELISA
procedure. Our results indicate the existence of linear IgE binding epitopes,
mainly located towards the N-terminal and C-terminal parts of the protein, as
recognized by IgE antibodies in the studied sera. The role of these short amino
acid sequences in the allergic reaction and their appropriateness for
immunotherapy calls for further investigation.
In conclusion, this thesis has contributed to the isolation, identification and
characterization of the allergens involved in a major occupational disease among
people who work with laboratory animals, namely rat allergy.
Keywords: allergen, laboratory animal allergy, rat urinary protein, Rat n 1.02,
a 2u-globulin, purification, chemiluminescence.
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Sammanfattning
Bayard C. Purification, characterization and immunological studies of rat urinary
proteins causing allergy in humans; Arbete och Hälsa 1998:15. National Institute
for Working Life, Solna, Sweden.
Upp till 30% av personer som hanterar försöksdjur drabbas av allergiska symtom
vilka kan relateras till kontakter med djur. Typiska symtom är ökat tårflöde,
urtikaria och astma. Dessa utvecklas ofta inom tre år efter första exponeringen.
Råttor är ett av det vanligaste försöksdjuren och deras urin innehåller en komplex
blandning av olika proteiner. Speciellt hanråttors urin har visat sig innehålla
allergiframkallande proteiner som t.ex. a 2u-globulin. Den allergiska reaktionen
kan uppkomma genom direkt kontakt med råtturin eller genom inandning av
luftburna partiklar i form av damm som härrör från intorkad urin. I urin från unga
fertila hanråttor är a 2u-globulin det kvantitativt mest förekommande proteinet.
Studiens syftet var att rena och identifiera de mest potenta allergenerna i råtturin
och sedan studera deras allergenicitet med känsliga delvis nya metoder. Dessutom
omfattade studien undersökningar av IgE bindande regioner på huvudallergenet,
Rat n 1.02, a 2u-globulin.
Råtturinproteiner separerades och renades genom ultrafiltrering och
högupplösande kromatografiska metoder. Storleksseparation utfördes genom
gelfiltrering följt av uppdelning efter laddning på en jonbytarkolonn. Även
isoelektrisk fokusering och SDS-polyakrylamidgelelektrofores användes för att
analysera proteinerna. Två dominerande proteiner identifierades som olika
varianter av samma moderprotein, a 2u-globulin, genom aminosyraanalys och
sekvenering samt masspektrometrisk bestämning. Härmed bevisades också att det
protein som tidigare kallats pre-albumin inte hade någon aminosyrasekvensiell
likhet med prealbumin (transthyretin) i råttserum. De beskrivna separations-
metoderna kan även användas för rening och studier av andra allergener.
IgE antikroppar som finns i sera från råttallergiska patienter studerades med
kemiluminiscens och immunoblotting. Individuella reaktivitetsmönster för de
elektroforetiskt separerade råtturinproteinerna kunde ses och IgE i alla patientsera
band till huvudproteinet, a 2u-globulin. Dock var detta protein inte alltid det mest
dominanta proteinet som kändes igen i alla sera. Med en specialutvecklad
luminometer kunde relativ mängd av IgE som bundit till olika råtturinproteiner
mätas i varje sera, samt diagram erhållas som illustrerade relativa mängder bundet
IgE.
Överlappande peptider av huvudallergenet Rat n 1.02 syntetiserades på fast fas
och undersöktes med en modifierad ELISA-metod för att lokalisera IgE bindande
regioner. Indikation på linjära IgE bindande epitoper erhölls vid proteinets N- och
C-terminala delar. Ytterligare studier av peptidernas roll för den allergiska
reaktionen och deras eventuella användbarhet inom immunoterapin bör dock
göras.
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Sammanfattningsvis kan sägas att denna studie har bidragit till isolering och
karakterisering av allergener, vilka ger upphov till yrkesrelaterad råttallergi bland
dem som arbetar med laboratoriedjur.
Nyckelord: allergener, laboratoriedjursallergi, råtturinproteiner, Rat n 1.02, a 2u-
globulin, rening, kemiluminiscens.
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